XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of March 31, 2023:

 

   Awards   Awards      Awards 
  

Reserved for

Issuance

   Issued & Outstanding  

Awards

Exercised

  

Available for

Grant

 
2019 Plan(1)   871,429    627,219    7,183    237,027 
Awards granted outside of the 2019 Plan(2)   -    37,037    11,364    - 

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.
Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the period ended March 31, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Contractual 
   Number of   Exercise   Term in 
   Options   Price   Years 
Outstanding at January 1, 2023   524,937   $2.351416    8.38 
Granted   17,532    2.00    10.0 
Exercised            
Forfeited            
Cancelled            
Expired            
Outstanding at March 31, 2023   542,469   $2.340058    8.20 
Exercisable at March 31, 2023   351,398   $1.777947    7.42 
Schedule of Assumptions used in Share-based Compensation

 

Volatility   257.64%
Risk-free interest rate   4.21%
Dividend yield   0.0%
Expected term   5.50 years 
Schedule of Restricted Stock Units Granted

 

       Weighted 
       Average 
   Number of   Grant Date 
   Units   Fair Value 
Outstanding at January 1, 2023   90,432   $1.43 
Granted   37,037    1.35 
Exercised and converted to common shares   (5,682)   4.40 
Forfeited        
Outstanding at March 31, 2023   121,787   $1.68 
Exercisable at March 31, 2023   30,466   $1.68 
Summary of Common Stock Warrants

The following table shows a summary of common stock warrants through March 31, 2023:

 

     Weighted    Weighted 
     Average    Average 
  Number of    Exercise    Contractual 
  Warrants   Price   Term in Years 
Outstanding at January 1, 2023   3,637,190    $5.16281    3.65 
Granted            
Exercised   (30,430)     0.69     
Forfeited            
Cancelled   (49,570)     1.18     
Expired            
Outstanding at March 31, 2023   3,557,190    $5.256569    3.47 
Exercisable at March 31, 2023   3,557,190    $5.256569    3.47